Retrophin to Present at Upcoming Investor Conferences

Rhea-AI Summary

Retrophin (NASDAQ: RTRX) is participating in two virtual investor conferences in August 2020. The William Blair Biotech Focus Conference will occur on August 6 at 3:00 p.m. ET, followed by the Canaccord Genuity 40th Annual Growth Conference on August 12 at 2:00 p.m. ET. Live webcasts and archived replays will be available for up to 30 days on their website.

Retrophin specializes in therapies for rare diseases, focusing on late-stage development of sparsentan for conditions like FSGS and IgAN, with ongoing research in other rare disorders.

SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Company management will participate in the following upcoming virtual investor conferences in August:

William Blair Biotech Focus Conference 2020
Date: Thursday, August 6, 2020
Time: 3:00 p.m. ET

Canaccord Genuity 40th Annual Growth Conference
Date: Wednesday, August 12, 2020
Time: 2:00 p.m. ET

Live webcasts will be available at http://ir.retrophin.com/events and archived replays will be accessible for up to 30 days.

About Retrophin

Retrophin is a biopharmaceutical company specializing in identifying, developing and delivering life-changing therapies to people living with rare disease. The Company’s approach centers on its pipeline featuring sparsentan, a product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN), rare disorders characterized by progressive scarring of the kidney often leading to end-stage renal disease. Research in additional rare diseases is also underway, including partnerships with leaders in patient advocacy and government research to identify potential therapeutics for NGLY1 deficiency and Alagille syndrome, conditions with no approved treatment options. Retrophin’s R&D efforts are supported by revenues from the Company’s commercial products Chenodal^®, Cholbam^®, Thiola^® and Thiola EC^®.

Retrophin.com

Contact:

Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@retrophin.com   

FAQ

What investor conferences will Retrophin participate in August 2020?

Retrophin will participate in the William Blair Biotech Focus Conference on August 6, 2020, and the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020.

What is the focus of Retrophin's product development?

Retrophin focuses on developing therapies for rare diseases, particularly targeting conditions like FSGS and IgAN with their product candidate sparsentan.

When will the William Blair Biotech Focus Conference take place?

The William Blair Biotech Focus Conference will take place on August 6, 2020, at 3:00 p.m. ET.

When is the Canaccord Genuity 40th Annual Growth Conference scheduled?

The Canaccord Genuity 40th Annual Growth Conference is scheduled for August 12, 2020, at 2:00 p.m. ET.

Where can I watch Retrophin's conference webcasts?

Live webcasts of Retrophin's conferences can be viewed at http://ir.retrophin.com/events, with archived replays available for 30 days.